Pristiq (Desvenlafaxine) for Myeloma

Overview
Pristiq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat major depression disorder. Pristiq may also be prescribed to manage neuropathic pain, a common side effect of treatment for myeloma. Pristiq is also known by its drug name, desvenlafaxine.

Pristiq is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class. Pristiq is believed to work by changing the balance of neurotransmitters in the brain.

How do I take it?
Pristiq is taken once daily.

Pristiq comes in tablet form.

Side effects
The FDA-approved label for Pristiq lists common side effects including nausea, dizziness, insomnia, excess sweating, constipation, drowsiness, decreased appetite, anxiety, and sexual dysfunction.

Rare but serious side effects listed for Pristiq include worsening depression and suicidal thoughts, serotonin syndrome, elevated blood pressure, abnormal bleeding, glaucoma, manic thoughts and behaviors, cardiovascular disease, elevated cholesterol, kidney problems, seizure, and lung disease.

For more details about this treatment, visit:

Pristiq — RxList
http://www.rxlist.com/pristiq-drug.htm

Pain, Pain, Go Away: Antidepressants and Pain Management — National Center for Biotechnology Information
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27...

Peripheral neuropathy — Myeloma UK
https://www.myeloma.org.uk/wp-content/uploads/2...